13F-HR filed by GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 16 holding rows worth $1,551,148,266.
- Accession
- 0001123292-25-000079
- Filer
- CIK 882095
- Filed
- 2025-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 16 entries on the cover page, a total value of $1,551,148,266 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,551,148,266 with VALUE read as dollars as filed, 13F file number 028-25078. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGilead Therapeutics A1 Unlimited Co
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 6,720,803 | $515,418,382 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 16,707,477 | $461,727,194 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 30,061,124 | $447,610,136 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 2,209,471 | $34,865,452 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 452,527 | $19,028,760 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 4,126,119 | $15,431,685 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 5,319,148 | $15,292,551 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 4,854,443 | $15,000,229 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 9,105,451 | $8,695,706 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 16,635,286 | $6,986,820 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K209 | COM NEW | 1,875,945 | $3,770,649 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 2,008,338 | $3,293,674 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,156,689 | $2,463,748 | dollars as filed | |
| BARINTHUS BIOTHERAPEUTICS PL | 91864C107 | ADS | 620,351 | $749,384 | dollars as filed | |
| AGENUS INC | 00847G804 | COM NEW | 231,663 | $634,757 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 188,567 | $179,139 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001123292-25-000079 | this filing | 2025-02-13 | acceptance time not in the bulk data set |